{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:59:49Z","timestamp":1768780789853,"version":"3.49.0"},"reference-count":283,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019276","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Amap\u00e1","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bmc.2020.115745","type":"journal-article","created":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T11:31:59Z","timestamp":1599564719000},"page":"115745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Druggable targets from coronaviruses for designing new antiviral drugs"],"prefix":"10.1016","volume":"28","author":[{"given":"Leandro Rocha","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Fernando","family":"da Silva Santos-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falia","family":"de Andrade Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00canio Jos\u00e9","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Xavier de Ara\u00fajo-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvia Helena","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edeildo Ferreira","family":"da Silva-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/MMBR.69.4.635-664.2005","article-title":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus","volume":"69","author":"Weiss","year":"2005","journal-title":"Microbiol Mol Biol Rev"},{"issue":"7","key":"10.1016\/j.bmc.2020.115745_b0010","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/JVI.06540-11","article-title":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavi","volume":"86","author":"Woo","year":"2012","journal-title":"J Virol"},{"issue":"9371","key":"10.1016\/j.bmc.2020.115745_b0015","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.bmc.2020.115745_b0020","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med"},{"issue":"10223","key":"10.1016\/j.bmc.2020.115745_b0025","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b0030","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat Microbiol"},{"issue":"March","key":"10.1016\/j.bmc.2020.115745_b0035","first-page":"4","article-title":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19","author":"Adhanom Ghebreyesus","year":"2020","journal-title":"World Heal Organ"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drudis.2017.10.007","article-title":"Medicinal chemistry in drug discovery in big pharma: past, present and future","volume":"23","author":"Campbell","year":"2018","journal-title":"Drug Discov Today"},{"issue":"12","key":"10.1016\/j.bmc.2020.115745_b0045","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.drudis.2016.08.001","article-title":"Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders","volume":"21","author":"Bawa","year":"2016","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.bmc.2020.115745_b0050","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrd3368","article-title":"Impact of high-throughput screening in biomedical research","volume":"10","author":"Macarron","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.bmc.2020.115745_b0055","first-page":"2502","article-title":"Combinatorial chemistry: A review","volume":"4","author":"Rasheed","year":"2013","journal-title":"J Pharm Sci Res"},{"issue":"3","key":"10.1016\/j.bmc.2020.115745_b0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1021\/cc700187t","article-title":"Application of combinatorial chemistry science on modern drug discovery","volume":"10","author":"Kennedy","year":"2008","journal-title":"J Comb Chem"},{"key":"10.1016\/j.bmc.2020.115745_b0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.addr.2016.05.009","article-title":"Tumor-targeting peptides from combinatorial libraries","volume":"110\u2013111","author":"Liu","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2020.115745_b0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cbpa.2017.03.017","article-title":"Combinatorial chemistry in drug discovery","volume":"38","author":"Liu","year":"2017","journal-title":"Curr Opin Chem Biol"},{"issue":"2\u20133","key":"10.1016\/j.bmc.2020.115745_b0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pbiomolbio.2014.09.008","article-title":"Fragment screening by SPR and advanced application to GPCRs","volume":"116","author":"Shepherd","year":"2014","journal-title":"Prog Biophys Mol Biol"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrd3926","article-title":"Fragment-based lead discovery grows up","volume":"12","author":"Baker","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"spe","key":"10.1016\/j.bmc.2020.115745_b0085","article-title":"Drug discovery and computational strategies in the multitarget drugs era","volume":"54","author":"Viana J de","year":"2018","journal-title":"Brazilian J Pharm Sci"},{"issue":"10","key":"10.1016\/j.bmc.2020.115745_b0090","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nbt1338","article-title":"Drug\u2014target network","volume":"25","author":"Y\u0131ld\u0131r\u0131m","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"23","key":"10.1016\/j.bmc.2020.115745_b0095","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.2174\/09298673113209990001","article-title":"Virtual screening strategies in drug discovery: A critical review","volume":"20","author":"Lavecchia","year":"2013","journal-title":"Curr Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2020.115745_b0100","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2174\/1568026615666150825142002","article-title":"Advances in computational structure-based drug design and application in drug discovery","volume":"16","author":"Wang","year":"2015","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2020.115745_b0105","doi-asserted-by":"crossref","unstructured":"Khanna V, Ranganathan S, Petrovsky N. Rational Structure-Based Drug Design. Elsevier Ltd.; 2019. doi:10.1016\/b978-0-12-809633-8.20275-6.","DOI":"10.1016\/B978-0-12-809633-8.20275-6"},{"key":"10.1016\/j.bmc.2020.115745_b0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ymeth.2017.09.008","article-title":"In silico methods for design of biological therapeutics","volume":"131","author":"Roy","year":"2017","journal-title":"Methods"},{"issue":"3","key":"10.1016\/j.bmc.2020.115745_b0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1367-5931(03)00057-7","article-title":"Computational design strategies for combinatorial libraries","volume":"7","author":"Rose","year":"2003","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.bmc.2020.115745_b0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.compbiomed.2019.01.008","article-title":"In silico approaches and tools for the prediction of drug metabolism and fate: A review","volume":"106","author":"Kazmi","year":"2019","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.bmc.2020.115745_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111602","article-title":"Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work","volume":"182","author":"Kumar","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115745_b0130","doi-asserted-by":"crossref","first-page":"112275","DOI":"10.1016\/j.ejmech.2020.112275","article-title":"A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery","volume":"195","author":"Pillaiyar","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.bmc.2020.115745_b0140","doi-asserted-by":"crossref","first-page":"117652","DOI":"10.1016\/j.lfs.2020.117652","article-title":"In silico studies on therapeutic agents for COVID-19: Drug repurposing approach","volume":"252","author":"Shah","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2020.115745_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2020.06.016","article-title":"In silico prediction of potential inhibitors for the Main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing","author":"Kumar","year":"2020","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.bmc.2020.115745_b0150","doi-asserted-by":"crossref","first-page":"117883","DOI":"10.1016\/j.lfs.2020.117883","article-title":"Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements","volume":"256","author":"Pandey","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2020.115745_b0155","doi-asserted-by":"crossref","first-page":"107325","DOI":"10.1016\/j.compbiolchem.2020.107325","article-title":"Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors","volume":"88","author":"Jim\u00e9nez-Alberto","year":"2020","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.bmc.2020.115745_b0160","doi-asserted-by":"crossref","first-page":"104228","DOI":"10.1016\/j.micpath.2020.104228","article-title":"In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect","volume":"145","author":"Andreani","year":"2020","journal-title":"Microb Pathog"},{"issue":"3","key":"10.1016\/j.bmc.2020.115745_b0165","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.encep.2020.05.006","article-title":"Repurposing chlorpromazine to treat COVID-19: The reCoVery study","volume":"46","author":"Plaze","year":"2020","journal-title":"Encephale"},{"key":"10.1016\/j.bmc.2020.115745_b0170","doi-asserted-by":"crossref","unstructured":"Hage-Melim LI da S, Federico LB, de Oliveira NKS, et al. Virtual screening, ADME\/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19. Life Sci. 2020;256:117963. doi:10.1016\/j.lfs.2020.117963.","DOI":"10.1016\/j.lfs.2020.117963"},{"key":"10.1016\/j.bmc.2020.115745_b0175","doi-asserted-by":"crossref","first-page":"105960","DOI":"10.1016\/j.ijantimicag.2020.105960","article-title":"Structural and molecular modeling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection","author":"Fantini","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2020.115745_b0180","doi-asserted-by":"crossref","first-page":"117627","DOI":"10.1016\/j.lfs.2020.117627","article-title":"Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease","volume":"251","author":"Kandeel","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2020.115745_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2020.07.004","article-title":"An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics","author":"Wang","year":"2020","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.bmc.2020.115745_b0190","doi-asserted-by":"crossref","unstructured":"Xiu S, Dick A, Ju H, et al. Inhibitors of SARS-CoV-2 entry: current and future opportunities. J Med Chem. 2020;As Soon As. doi:10.1021\/acs.jmedchem.0c00502.","DOI":"10.1021\/acs.jmedchem.0c00502"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0195","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3181\/00379727-121-30734","article-title":"A new virus isolated from the human respiratory tract","volume":"121","author":"Hamre","year":"1966","journal-title":"Proc Soc Exp Biol Med"},{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b0200","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1073\/pnas.57.4.933","article-title":"Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease","volume":"57","author":"McIntosh","year":"1967","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b0205","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm1024","article-title":"Identification of a new human coronavirus","volume":"10","author":"Van Der Hoek","year":"2004","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0210","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.79.2.884-895.2005","article-title":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia","volume":"79","author":"Woo","year":"2005","journal-title":"J Virol"},{"issue":"9366","key":"10.1016\/j.bmc.2020.115745_b0215","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2020.115745_b0220","unstructured":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 (Based on data as of the 31 December 2003.). World Health Organization."},{"key":"10.1016\/j.bmc.2020.115745_b0225","unstructured":"World Health Organization W. Middle east respiratory syndrome coronavirus."},{"issue":"12","key":"10.1016\/j.bmc.2020.115745_b0230","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3201\/eid1012.040520","article-title":"Antibodies to SARS coronavirus in civets","volume":"10","author":"Tu","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"18","key":"10.1016\/j.bmc.2020.115745_b0235","doi-asserted-by":"crossref","first-page":"11892","DOI":"10.1128\/JVI.79.18.11892-11900.2005","article-title":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms","volume":"79","author":"Kan","year":"2005","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.bmc.2020.115745_b0240","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1128\/JVI.02420-14","article-title":"Discovery of a novel coronavirus, china rattus coronavirus HKU24, from Norway rats supports the murine origin of betacoronavirus 1 and has implications for the ancestor of betacoronavirus lineage A","volume":"89","author":"Lau","year":"2015","journal-title":"J Virol"},{"issue":"23","key":"10.1016\/j.bmc.2020.115745_b0245","doi-asserted-by":"crossref","first-page":"11858","DOI":"10.1128\/JVI.01755-15","article-title":"Evidence for an ancestral association of human coronavirus 229E with bats","volume":"89","author":"Corman","year":"2015","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0250","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tim.2016.09.001","article-title":"Molecular evolution of human coronavirus genomes","volume":"25","author":"Forni","year":"2017","journal-title":"Trends Microbiol"},{"issue":"6","key":"10.1016\/j.bmc.2020.115745_b0255","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"issue":"3","key":"10.1016\/j.bmc.2020.115745_b0260","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2020.115745_b0265","unstructured":"World Health Organization. Coronavirus Disease (COVID-19) Dashboard."},{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b0270","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1086\/382681","article-title":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome","volume":"38","author":"Cheng","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.bmc.2020.115745_b0275","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2004-10-4166","article-title":"Chemokine up-regulation in SARS-coronavirus\u2013infected, monocyte-derived human dendritic cells","volume":"106","author":"Law","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bmc.2020.115745_b0280","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1099\/vir.0.81624-0","article-title":"Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells","volume":"87","author":"Spiegel","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bmc.2020.115745_b0285","doi-asserted-by":"crossref","unstructured":"Fehr AR, Stanle, P. Coronaviruses: An overview of their replication and pathogenesis. In: Maier HJ, Bickerton E, Britton P, editors. Coronaviruses: Methods and Protocols. vol. 1282. Methods in Molecular Biology. Springer New York; 2015, pp. 1\u201323. doi:10.1007\/978-1-4939-2438-7.","DOI":"10.1007\/978-1-4939-2438-7_1"},{"issue":"14","key":"10.1016\/j.bmc.2020.115745_b0290","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Middle east respiratory syndrome coronavirus (MERS-CoV): announcement of the coronavirus study group","volume":"87","author":"de Groot","year":"2013","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.bmc.2020.115745_b0295","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/M13-2486","article-title":"Clinical course and outcomes of critically ill patients with middle east respiratory syndrome coronavirus infection","volume":"160","author":"Arabi","year":"2014","journal-title":"Ann Intern Med"},{"issue":"9997","key":"10.1016\/j.bmc.2020.115745_b0300","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(15)60454-8","article-title":"Middle East respiratory syndrome","volume":"386","author":"Zumla","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0305","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jiph.2016.04.008","article-title":"Clinical spectrum of the Middle East respiratory syndrome coronavirus (MERS-CoV)","volume":"10","author":"Senga","year":"2017","journal-title":"J Infect Public Health"},{"issue":"8","key":"10.1016\/j.bmc.2020.115745_b0310","first-page":"1339","article-title":"Isolation of MERS coronavirus from dromedary camel, Qatar, 2014","volume":"20","author":"Stalin Raj","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0315","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1473-3099(13)70690-X","article-title":"Middle East respiratory syndrome coronavirus in dromedary camels: An outbreak investigation","volume":"14","author":"Haagmans","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"26","key":"10.1016\/j.bmc.2020.115745_b0320","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1401505","article-title":"Evidence for camel-to-human transmission of MERS coronavirus","volume":"370","author":"Azhar","year":"2014","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.bmc.2020.115745_b0325","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1128\/JVI.01352-15","article-title":"Middle east respiratory syndrome coronavirus nsp1 inhibits host gene expression by selectively targeting mRNAs transcribed in the Nucleus while Sparing mRNAs of cytoplasmic origin","volume":"89","author":"Lokugamage","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2020.115745_b0330","doi-asserted-by":"crossref","unstructured":"Matthews KL, Coleman CM, van der Meer Y, Snijder EJ, Frieman MB. The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling. J Gen Virol. 2014;95(PART 4):874\u2013882. doi:10.1099\/vir.0.062059-0.","DOI":"10.1099\/vir.0.062059-0"},{"issue":"22","key":"10.1016\/j.bmc.2020.115745_b0335","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.1128\/JVI.01845-13","article-title":"Middle east respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist","volume":"87","author":"Niemeyer","year":"2013","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.bmc.2020.115745_b0340","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3810\/pgm.2009.09.2051","article-title":"The first pandemic of the 21st century: A review of the 2009 pandemic variant influenza A (H1N1) virus","volume":"121","author":"Scalera","year":"2009","journal-title":"Postgrad Med"},{"issue":"6490","key":"10.1016\/j.bmc.2020.115745_b0345","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science (80-)"},{"issue":"16","key":"10.1016\/j.bmc.2020.115745_b0350","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1128\/JVI.00645-06","article-title":"Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy","volume":"80","author":"Neuman","year":"2006","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.bmc.2020.115745_b0355","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1099\/vir.0.80671-0","article-title":"Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S M and E","volume":"86","author":"Nal","year":"2005","journal-title":"J Gen Virol"},{"issue":"21","key":"10.1016\/j.bmc.2020.115745_b0360","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1007\/s00018-004-4242-5","article-title":"Angiotensin-converting enzyme 2: A functional receptor for SARS coronavirus","volume":"61","author":"Kuhn","year":"2004","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"10.1016\/j.bmc.2020.115745_b0365","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"issue":"7440","key":"10.1016\/j.bmc.2020.115745_b0370","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.bmc.2020.115745_b0375","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmc.2020.115745_b0380","first-page":"57","article-title":"The coronavirus replicase","volume":"287","author":"Ziebuhr","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0385","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.virol.2004.11.038","article-title":"Programmed ribosomal frameshifting in decoding the SARS-CoV genome","volume":"332","author":"Baranov","year":"2005","journal-title":"Virology"},{"issue":"24","key":"10.1016\/j.bmc.2020.115745_b0390","doi-asserted-by":"crossref","first-page":"13600","DOI":"10.1128\/JVI.78.24.13600-13612.2004","article-title":"Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity","volume":"78","author":"Harcourt","year":"2004","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.bmc.2020.115745_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00473-12","article-title":"Genomic characterization of a newly discovered coronavirus","volume":"3","author":"Van Boheemen","year":"2012","journal-title":"MBio"},{"issue":"24","key":"10.1016\/j.bmc.2020.115745_b0400","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1016\/j.bmcl.2005.09.012","article-title":"Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor","volume":"15","author":"Martina","year":"2005","journal-title":"Bioorganic Med Chem Lett"},{"issue":"5","key":"10.1016\/j.bmc.2020.115745_b0405","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9050331","article-title":"The human coronavirus disease covid-19: Its origin, characteristics, and insights into potential drugs and its mechanisms","volume":"9","author":"Alanagreh","year":"2020","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: Current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol J"},{"issue":"6","key":"10.1016\/j.bmc.2020.115745_b0415","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"issue":"7592","key":"10.1016\/j.bmc.2020.115745_b0420","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature16988","article-title":"Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer","volume":"531","author":"Walls","year":"2016","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.bmc.2020.115745_b0425","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J Virol"},{"issue":"7592","key":"10.1016\/j.bmc.2020.115745_b0430","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature17200","article-title":"Pre-fusion structure of a human coronavirus spike protein","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0435","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity Of The SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"5742","key":"10.1016\/j.bmc.2020.115745_b0440","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structural biology: Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science (80-)"},{"issue":"6483","key":"10.1016\/j.bmc.2020.115745_b0445","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science (80-)"},{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b0450","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1128\/JVI.02615-14","article-title":"Receptor recognition mechanisms of coronaviruses: a decade of structural studies","volume":"89","author":"Li","year":"2015","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.bmc.2020.115745_b0455","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"7807","key":"10.1016\/j.bmc.2020.115745_b0460","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0465","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.bmc.2020.115745_b0470","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc Natl Acad Sci"},{"issue":"24","key":"10.1016\/j.bmc.2020.115745_b0475","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient Activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2","volume":"84","author":"Matsuyama","year":"2010","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","article-title":"Targeting the entry step of SARS-CoV-2: a promising therapeutic approach","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b0485","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res"},{"issue":"22","key":"10.1016\/j.bmc.2020.115745_b0490","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.0400576101","article-title":"Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides","volume":"101","author":"Bosch","year":"2004","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0495","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.antiviral.2005.10.005","article-title":"Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction","volume":"69","author":"Ho","year":"2006","journal-title":"Antiviral Res"},{"issue":"January","key":"10.1016\/j.bmc.2020.115745_b0500","article-title":"Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic","volume":"363","author":"Liu","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0505","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbrc.2005.02.117","article-title":"Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain","volume":"330","author":"Ni","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0510","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbrc.2004.04.141","article-title":"Following the rule: Formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors","volume":"319","author":"Zhu","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.bmc.2020.115745_b0515","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbrc.2004.05.046","article-title":"Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein","volume":"319","author":"Yuan","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b0520","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbrc.2003.11.054","article-title":"The SARS-CoV S glycoprotein: Expression and functional characterization","volume":"312","author":"Xiao","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.bmc.2020.115745_b0525","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.bmc.2020.115745_b0530","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1128\/JVI.78.9.4552-4560.2004","article-title":"Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor","volume":"78","author":"Babcock","year":"2004","journal-title":"J Virol"},{"issue":"18","key":"10.1016\/j.bmc.2020.115745_b0535","doi-asserted-by":"crossref","first-page":"9313","DOI":"10.1128\/JVI.01237-15","article-title":"A coronavirus E protein is present in two distinct pools with different effects on assembly and the secretory pathway","volume":"89","author":"Westerbeck","year":"2015","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0540","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.virol.2006.01.028","article-title":"Biochemical and functional characterization of the membrane association and membrane permeabilizing activity of the severe acute respiratory syndrome coronavirus envelope protein","volume":"349","author":"Liao","year":"2006","journal-title":"Virology"},{"issue":"18","key":"10.1016\/j.bmc.2020.115745_b0545","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1074\/jbc.M114.560094","article-title":"Structure of a conserved golgi complex-targeting signal in coronavirus envelope proteins","volume":"289","author":"Li","year":"2014","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0550","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virol.2011.03.029","article-title":"Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein","volume":"415","author":"Nieto-Torres","year":"2011","journal-title":"Virology"},{"issue":"22","key":"10.1016\/j.bmc.2020.115745_b0555","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1091\/mbc.e10-04-0338","article-title":"The SARS Coronavirus E Protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis. Nusrat A, ed.","volume":"21","author":"Teoh","year":"2010","journal-title":"Mol Biol Cell"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0560","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.virol.2012.07.005","article-title":"Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids","volume":"432","author":"Verdi\u00e1-B\u00e1guena","year":"2012","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.bmc.2020.115745_b0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1004077","article-title":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis","volume":"10","author":"Nieto-Torres","year":"2014","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0570","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BJ20050698","article-title":"Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors","volume":"392","author":"Yang","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2020.115745_b0575","doi-asserted-by":"crossref","unstructured":"Jimenez-Guarde\u00f1o JM, Nieto-Torres JL, DeDiego ML, et al. The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis. Basler CF, ed. PLoS Pathog. 2014;10(8):e1004320. doi:10.1371\/journal.ppat.1004320.","DOI":"10.1371\/journal.ppat.1004320"},{"issue":"xxxx","key":"10.1016\/j.bmc.2020.115745_b0580","article-title":"Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19","author":"Tilocca","year":"2020","journal-title":"Microbes Infect"},{"issue":"6","key":"10.1016\/j.bmc.2020.115745_b0585","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.bbamem.2018.02.017","article-title":"Structural model of the SARS coronavirus E channel in LMPG micelles","volume":"1860","author":"Surya","year":"2018","journal-title":"Biochim Biophys Acta - Biomembr"},{"key":"10.1016\/j.bmc.2020.115745_b0590","doi-asserted-by":"crossref","unstructured":"Do A. ll Perspective Chemistry and Biology of SARS-CoV-2. Published online 2020:1-13. doi:10.1016\/j.chempr.2020.04.023.","DOI":"10.1016\/j.chempr.2020.04.023"},{"issue":"17\u201318","key":"10.1016\/j.bmc.2020.115745_b0595","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.drudis.2012.05.002","article-title":"Viral targets of acylguanidines","volume":"17","author":"Gazina","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2020.115745_b0600","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2018.05.030","article-title":"Acylguanidine derivatives of zanamivir and oseltamivir: Potential orally available prodrugs against influenza viruses","volume":"154","author":"Hsu","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0605","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.virol.2006.05.028","article-title":"Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication","volume":"353","author":"Wilson","year":"2006","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.bmc.2020.115745_b0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000511","article-title":"Structure and inhibition of the SARS coronavirus envelope protein ion channel","volume":"5","author":"Pervushin","year":"2009","journal-title":"PLoS Pathog"},{"issue":"5626","key":"10.1016\/j.bmc.2020.115745_b0615","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science (80-)"},{"issue":"6","key":"10.1016\/j.bmc.2020.115745_b0620","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: Update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2020.115745_b0625","doi-asserted-by":"crossref","unstructured":"Tahir ul Qamar M, Alqahtani SM, Alamri MA, Chen L-L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. Published online March 2020. doi:10.1016\/j.jpha.2020.03.009.","DOI":"10.1016\/j.jpha.2020.03.009"},{"issue":"32","key":"10.1016\/j.bmc.2020.115745_b0630","doi-asserted-by":"crossref","first-page":"19403","DOI":"10.1074\/jbc.M115.651463","article-title":"Ligand-induced dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 protease (3CLpro): Implications for nsp5 regulation and the development of antivirals","volume":"290","author":"Tomar","year":"2015","journal-title":"J Biol Chem"},{"issue":"6489","key":"10.1016\/j.bmc.2020.115745_b0635","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science (80-)"},{"issue":"20","key":"10.1016\/j.bmc.2020.115745_b0640","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1016\/j.bmcl.2008.08.082","article-title":"Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors","volume":"18","author":"Ghosh","year":"2008","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.bmc.2020.115745_b0645","doi-asserted-by":"crossref","first-page":"104859","DOI":"10.1016\/j.phrs.2020.104859","article-title":"Candidate drugs against SARS-CoV-2 and COVID-19","author":"McKee","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bmc.2020.115745_b0650","doi-asserted-by":"crossref","unstructured":"Yu R, Chen L, Lan R, Shen R, Li P. Computational screening of antagonist against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking. Int J Antimicrob Agents. 2020;2(xxxx):106012. doi:10.1016\/j.ijantimicag.2020.106012.","DOI":"10.1016\/j.ijantimicag.2020.106012"},{"key":"10.1016\/j.bmc.2020.115745_b0655","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","author":"Wu","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2020.115745_b0660","doi-asserted-by":"crossref","unstructured":"B\u00e1ez-Santos YM, St. John SE, Mesecar AD. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds. Antiviral Res. 2015;115:21\u201338. doi:10.1016\/j.antiviral.2014.12.015.","DOI":"10.1016\/j.antiviral.2014.12.015"},{"key":"10.1016\/j.bmc.2020.115745_b0665","doi-asserted-by":"crossref","unstructured":"Barretto N, Jukneliene D, Ratia K, Chen Z, Mesecar AD, Baker SC. Deubiquitinating activity of the SARS-CoV papain-like protease. In: Advances in Experimental Medicine and Biology. Vol. 581; 2006:37\u201341. doi:10.1007\/978-0-387-33012-9_5.","DOI":"10.1007\/978-0-387-33012-9_5"},{"issue":"24","key":"10.1016\/j.bmc.2020.115745_b0670","doi-asserted-by":"crossref","first-page":"15199","DOI":"10.1128\/JVI.79.24.15199-15208.2005","article-title":"The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme","volume":"79","author":"Lindner","year":"2005","journal-title":"J Virol"},{"issue":"13","key":"10.1016\/j.bmc.2020.115745_b0675","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/JVI.02220-08","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-\u03baB signaling","volume":"83","author":"Frieman","year":"2009","journal-title":"J Virol"},{"issue":"15","key":"10.1016\/j.bmc.2020.115745_b0680","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1073\/pnas.0510851103","article-title":"Severe acute respiratory syndrome coronavirus papain-like-protease: Structure of a viral deubiquitinating enzyme","volume":"103","author":"Ratia","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0685","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2014.06.011","article-title":"Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features","volume":"109","author":"Lei","year":"2014","journal-title":"Antiviral Res"},{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b0690","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/0022-1317-81-4-853","article-title":"Virus-encoded proteinases and proteolytic processing in the Nidovirales","volume":"81","author":"Ziebuhr","year":"2000","journal-title":"J Gen Virol"},{"issue":"30","key":"10.1016\/j.bmc.2020.115745_b0695","doi-asserted-by":"crossref","first-page":"21490","DOI":"10.1016\/S0021-9258(19)72604-0","article-title":"A human RNA viral cysteine proteinase that depends upon a unique Zn2+-binding finger connecting the two domains of a papain-like fold (Journal of Biological Chemistry (1999) 274 (14400\u201314405))","volume":"274","author":"Herold","year":"1999","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.bmc.2020.115745_b0700","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1021\/jm1004489","article-title":"Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein\u2013ligand X-ray structure and biological evaluation","volume":"53","author":"Ghosh","year":"2010","journal-title":"J Med Chem"},{"issue":"17","key":"10.1016\/j.bmc.2020.115745_b0705","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1093\/nar\/gkv838","article-title":"Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerase-containing protein of all nidoviruses","volume":"43","author":"Lehmann","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.bmc.2020.115745_b0710","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1093\/nar\/17.12.4847","article-title":"Coronavirus genome: Prediction of putative functional domains in the non-structural polyprotein by comparative amino acid sequence analysis","volume":"17","author":"Gorbalenya","year":"1989","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2020.115745_b0715","doi-asserted-by":"crossref","unstructured":"Snijder EJ, Decroly E, Ziebuhr J. The Nonstructural proteins directing coronavirus RNA synthesis and processing. In: Advances in virus research. Vol. 96. 1st ed. Elsevier Inc.; 2016, pp. 59\u2013126. doi:10.1016\/bs.aivir.2016.08.008.","DOI":"10.1016\/bs.aivir.2016.08.008"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0720","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/nar\/gkp904","article-title":"The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent","volume":"38","author":"te Velthuis","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"37","key":"10.1016\/j.bmc.2020.115745_b0725","doi-asserted-by":"crossref","first-page":"E3900","DOI":"10.1073\/pnas.1323705111","article-title":"One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities","volume":"111","author":"Subissi","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6492","key":"10.1016\/j.bmc.2020.115745_b0730","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science (80-)"},{"issue":"15","key":"10.1016\/j.bmc.2020.115745_b0735","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","article-title":"The antiviral compound remdesivir potently inhibits RNAdependent RNA polymerase from Middle East respiratory syndrome coronavirus","volume":"295","author":"Gordon","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2020.115745_b0740","first-page":"1","article-title":"Polymerases and their emerging roles in antiviral therapy","author":"Ganeshpurkar","year":"2019","journal-title":"Viral Polymerases"},{"issue":"May","key":"10.1016\/j.bmc.2020.115745_b0745","first-page":"19","article-title":"COVID-19 target: A specific target for novel coronavirus detection","volume":"20","author":"Kakhki","year":"2020","journal-title":"Gene Reports"},{"key":"10.1016\/j.bmc.2020.115745_b0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128741","article-title":"Azafluorene derivatives as inhibitors of SARS CoV-2 RdRp: Synthesis, physicochemical, quantum chemical, modeling and molecular docking analysis","volume":"1220","author":"Venkateshan","year":"2020","journal-title":"J Mol Struct"},{"issue":"xxxx","key":"10.1016\/j.bmc.2020.115745_b0755","first-page":"3","article-title":"Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking","volume":"2","author":"Yu","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2020.115745_b0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2020.04.008","article-title":"Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase","author":"Mirza","year":"2020","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.bmc.2020.115745_b0765","doi-asserted-by":"crossref","unstructured":"Elfiky AA. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci. Published online 2020:117592. doi:10.1016\/j.lfs.2020.117592.","DOI":"10.1016\/j.lfs.2020.117592"},{"key":"10.1016\/j.bmc.2020.115745_b0770","doi-asserted-by":"crossref","unstructured":"Yin W, Mao C, Luan X, et al. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science (80-). 2020;1504(June):eabc1560. doi:10.1126\/science.abc1560.","DOI":"10.1126\/science.abc1560"},{"key":"10.1016\/j.bmc.2020.115745_b0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2020.06.013","article-title":"Characteristics and therapeutic options of the coronavirus disease 2019","author":"Huang","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"xxxx","key":"10.1016\/j.bmc.2020.115745_b0780","article-title":"Evaluating the potential of different inhibitors on RNA-dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2: A molecular modeling approach","author":"Choudhury","year":"2020","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.bmc.2020.115745_b0785","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1099\/jmm.0.001203","article-title":"Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2","author":"Pokhrel","year":"2020","journal-title":"J Med Microbiol"},{"issue":"3","key":"10.1016\/j.bmc.2020.115745_b0790","article-title":"Anti-HIV and Anti-HCV drugs are the putative inhibitors of RNA-dependent-RNA polymerase activity of NSP12 of the SARS CoV-2 (COVID-19)","volume":"8","author":"Beg","year":"2020","journal-title":"Pharm Pharmacol Int J"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0795","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.biochem.76.052305.115300","article-title":"Structure and mechanism of helicases and nucleic acid translocases","volume":"76","author":"Singleton","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bmc.2020.115745_b0800","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virusres.2014.12.001","article-title":"What we know but do not understand about nidovirus helicases","volume":"202","author":"Lehmann","year":"2015","journal-title":"Virus Res"},{"issue":"11","key":"10.1016\/j.bmc.2020.115745_b0805","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1128\/JVI.78.11.5619-5632.2004","article-title":"Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase","volume":"78","author":"Ivanov","year":"2004","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.bmc.2020.115745_b0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mSphere.00235-16","article-title":"Biochemical characterization of middle east respiratory syndrome coronavirus helicase","volume":"1","author":"Adedeji","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.bmc.2020.115745_b0815","first-page":"1","article-title":"SARS-coronavirus-2 Nsp13 Possesses NTPase and RNA helicase activities that can be inhibited by bismuth salts","volume":"12250","author":"Shu","year":"2020","journal-title":"Virol Sin"},{"issue":"10","key":"10.1016\/j.bmc.2020.115745_b0820","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002294","article-title":"Biochemical and structural insights into the mechanisms of sars coronavirus RNA ribose 2\u2032-O-methylation by nsp16\/nsp10 protein complex","volume":"7","author":"Chen","year":"2011","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.bmc.2020.115745_b0825","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bcp.2012.08.012","article-title":"Development of chemical inhibitors of the SARS coronavirus: Viral helicase as a potential target","volume":"84","author":"Keum","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.bmc.2020.115745_b0830","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-2836(03)00865-9","article-title":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage","volume":"331","author":"Snijder","year":"2003","journal-title":"J Mol Biol"},{"issue":"9","key":"10.1016\/j.bmc.2020.115745_b0835","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1099\/vir.0.19424-0","article-title":"Mechanisms and enzymes involved in SARS coronavirus genome expression","volume":"84","author":"Thiel","year":"2003","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b0840","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.bbrc.2006.03.069","article-title":"Tertiary structure prediction of SARS coronavirus helicase","volume":"343","author":"Bernini","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"41","key":"10.1016\/j.bmc.2020.115745_b0845","doi-asserted-by":"crossref","first-page":"39578","DOI":"10.1074\/jbc.C300328200","article-title":"The severe acute respiratory syndrome (SARS) coronavirus NTPase\/helicase belongs to a distinct class of 5\u2032 to 3\u2032 viral helicases","volume":"278","author":"Tanner","year":"2003","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.bmc.2020.115745_b0850","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1073\/pnas.0808790106","article-title":"Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase","volume":"106","author":"Chen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"10.1016\/j.bmc.2020.115745_b0855","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virusres.2013.05.001","article-title":"Characterization of the guanine-N7 methyltransferase activity of coronavirus nsp14 on nucleotide GTP","volume":"176","author":"Jin","year":"2013","journal-title":"Virus Res"},{"issue":"30","key":"10.1016\/j.bmc.2020.115745_b0860","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1073\/pnas.1508686112","article-title":"Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex","volume":"112","author":"Ma","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"10.1016\/j.bmc.2020.115745_b0865","doi-asserted-by":"crossref","first-page":"9372","DOI":"10.1073\/pnas.1201130109","article-title":"RNA 3\u2032-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10\/nsp14 exoribonuclease complex","volume":"109","author":"Bouvet","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.bmc.2020.115745_b0870","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2020.115745_b0875","first-page":"1","article-title":"Microbial chassis development for natural product biosynthesis","author":"Xu","year":"2020","journal-title":"Trends Biotechnol"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0880","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.synbio.2020.04.002","article-title":"Coordinated regulation for nature products discovery and overproduction in Streptomyces","volume":"5","author":"Zhou","year":"2020","journal-title":"Synth Syst Biotechnol"},{"key":"10.1016\/j.bmc.2020.115745_b0885","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ymben.2018.05.015","article-title":"Streptomyces species: Ideal chassis for natural product discovery and overproduction","volume":"50","author":"Liu","year":"2018","journal-title":"Metab Eng"},{"issue":"10","key":"10.1016\/j.bmc.2020.115745_b0890","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.chembiol.2017.09.013","article-title":"Unpackaging the roles of streptomyces natural products","volume":"24","author":"Jacob","year":"2017","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmc.2020.115745_b0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbpa.2018.12.007","article-title":"Natural product derived privileged scaffolds in drug discovery","volume":"52","author":"Davison","year":"2019","journal-title":"Curr Opin Chem Biol"},{"issue":"10","key":"10.1016\/j.bmc.2020.115745_b0900","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.chembiol.2017.08.008","article-title":"A link between linearmycin biosynthesis and extracellular vesicle genesis connects specialized metabolism and bacterial membrane physiology","volume":"24","author":"Hoefler","year":"2017","journal-title":"Cell Chem Biol"},{"issue":"28","key":"10.1016\/j.bmc.2020.115745_b0905","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1016\/j.tetlet.2007.05.079","article-title":"Carbocyclic sinefungin","volume":"48","author":"Yin","year":"2007","journal-title":"Tetrahedron Lett"},{"issue":"11","key":"10.1016\/j.bmc.2020.115745_b0910","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1002\/ijc.32376","article-title":"Abrogation of myofibroblast activities in metastasis and fibrosis by methyltransferase inhibition","volume":"145","author":"Sala","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bmc.2020.115745_b0915","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ejmech.2019.06.072","article-title":"Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents","volume":"179","author":"Cao","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"3","key":"10.1016\/j.bmc.2020.115745_b0920","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bbrc.2005.06.171","article-title":"Exogenous AdoMet and its analogue sinefungin differentially influence DNA cleavage by R. EcoP15I - Usefulness in SAGE","volume":"334","author":"Raghavendra","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.bmc.2020.115745_b0925","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00705-017-3345-x","article-title":"Structural basis of Zika virus methyltransferase inhibition by sinefungin","volume":"162","author":"Hercik","year":"2017","journal-title":"Arch Virol"},{"key":"10.1016\/j.bmc.2020.115745_b0930","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ejmech.2018.08.057","article-title":"Design, synthesis and in vitro anti-Zika virus evaluation of novel Sinefungin derivatives","volume":"157","author":"Tao","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"12","key":"10.1016\/j.bmc.2020.115745_b0935","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41429-019-0234-4","article-title":"Antiviral effect of sinefungin on in vitro growth of feline herpesvirus type 1","volume":"72","author":"Kuroda","year":"2019","journal-title":"J Antibiot (Tokyo)"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0940","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.antiviral.2014.02.002","article-title":"Yeast-based assays for the high-throughput screening of inhibitors of coronavirus RNA cap guanine-N7-methyltransferase","volume":"104","author":"Sun","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2020.115745_b0945","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.antiviral.2017.06.021","article-title":"Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay","volume":"144","author":"Aouadi","year":"2017","journal-title":"Antiviral Res"},{"issue":"8","key":"10.1016\/j.bmc.2020.115745_b0950","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/v6082991","article-title":"The coronavirus nucleocapsid is a multifunctional protein","volume":"6","author":"McBride","year":"2014","journal-title":"Viruses"},{"issue":"20","key":"10.1016\/j.bmc.2020.115745_b0955","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1021\/bi036155b","article-title":"Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein","volume":"43","author":"Huang","year":"2004","journal-title":"Biochemistry"},{"issue":"25","key":"10.1016\/j.bmc.2020.115745_b0960","doi-asserted-by":"crossref","first-page":"17134","DOI":"10.1074\/jbc.M602107200","article-title":"Crystal Structure of the Severe Acute Respiratory Syndrome (SARS) coronavirus nucleocapsid protein dimerization domain reveals evolutionary linkage between corona- and arteriviridae","volume":"281","author":"Yu","year":"2006","journal-title":"J Biol Chem"},{"issue":"xxx","key":"10.1016\/j.bmc.2020.115745_b0965","article-title":"Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites","author":"Kang","year":"2020","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"10.1016\/j.bmc.2020.115745_b0970","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbrc.2020.04.136","article-title":"Biochemical characterization of SARS-CoV-2 nucleocapsid protein","volume":"527","author":"Zeng","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0975","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2008.07.012","article-title":"Dissection and identification of regions required to form pseudoparticles by the interaction between the nucleocapsid (N) and membrane (M) proteins of SARS coronavirus","volume":"380","author":"Hatakeyama","year":"2008","journal-title":"Virology"},{"issue":"21","key":"10.1016\/j.bmc.2020.115745_b0980","doi-asserted-by":"crossref","first-page":"13285","DOI":"10.1128\/JVI.79.21.13285-13297.2005","article-title":"A major determinant for membrane protein interaction localizes to the carboxy-terminal domain of the mouse coronavirus nucleocapsid protein","volume":"79","author":"Hurst","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b0985","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.phytol.2007.10.001","article-title":"Flavonoids from carnation (Dianthus caryophyllus) and their antifungal activity","volume":"1","author":"Galeotti","year":"2008","journal-title":"Phytochem Lett"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b0990","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1172\/JCI11914","article-title":"Therapeutic potential of inhibition of the NF-\u03baB pathway in the treatment of inflammation and cancer","volume":"107","author":"Yamamoto","year":"2001","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.bmc.2020.115745_b0995","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijantimicag.2005.09.002","article-title":"Antimicrobial activity of flavonoids","volume":"26","author":"Cushnie","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"E-S1","key":"10.1016\/j.bmc.2020.115745_b1000","doi-asserted-by":"crossref","first-page":"ES60","DOI":"10.1017\/S0007114508965776","article-title":"Flavonoids: modulators of brain function?","volume":"99","author":"Spencer","year":"2008","journal-title":"Br J Nutr"},{"issue":"5","key":"10.1016\/j.bmc.2020.115745_b1005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jnutbio.2006.08.004","article-title":"Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair","volume":"18","author":"Katiyar","year":"2007","journal-title":"J Nutr Biochem"},{"issue":"20","key":"10.1016\/j.bmc.2020.115745_b1010","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.1158\/0008-5472.CAN-07-0625","article-title":"The unfolded protein response regulator GRP78\/BiP as a novel target for increasing chemosensitivity in malignant gliomas","volume":"67","author":"Pyrko","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.bmc.2020.115745_b1015","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jaci.2006.08.016","article-title":"Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy","volume":"118","author":"Williamson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.bmc.2020.115745_b1020","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1021\/jp0550762","article-title":"How Can (\u2212)-Epigallocatechin Gallate from Green Tea Prevent HIV-1 Infection? Mechanistic Insights from Computational Modeling and the Implication for Rational Design of Anti-HIV-1 Entry Inhibitors","volume":"110","author":"Hamza","year":"2006","journal-title":"J Phys Chem B"},{"issue":"10","key":"10.1016\/j.bmc.2020.115745_b1025","first-page":"4025","article-title":"Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin","volume":"29","author":"Hsieh","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bmc.2020.115745_b1030","article-title":"Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes","author":"Das","year":"2009","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b1035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2220\/biomedres.30.207","article-title":"Induction of apoptosis in human bladder cancer cells by green tea catechins","volume":"30","author":"Philips","year":"2009","journal-title":"Biomed Res"},{"key":"10.1016\/j.bmc.2020.115745_b1040","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.2147\/IJN.S31379","article-title":"A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide","volume":"7","author":"Roh","year":"2012","journal-title":"Int J Nanomed Radiat Technol Inst"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b1045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.virol.2006.01.029","article-title":"Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor","volume":"350","author":"Han","year":"2006","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b1050","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bmc.2014.12.028","article-title":"Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors","volume":"23","author":"Shimamoto","year":"2015","journal-title":"Bioorganic Med Chem"},{"issue":"6","key":"10.1016\/j.bmc.2020.115745_b1055","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.bmc.2016.01.052","article-title":"Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease","volume":"24","author":"Konno","year":"2016","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.bmc.2020.115745_b1060","doi-asserted-by":"crossref","unstructured":"Kumar V, Tan K, Wang Y, Lin S, Liang P. Bioorganic & Medicinal Chemistry Identification , synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors. 2016;24:3035\u20133042.","DOI":"10.1016\/j.bmc.2016.05.013"},{"key":"10.1016\/j.bmc.2020.115745_b1065","article-title":"\u03b1-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment","author":"Zhang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115745_b1070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2017.02.007","article-title":"Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CLPro inhibitors","volume":"141","author":"Kumar","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2020.115745_b1075","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ejmech.2017.05.045","article-title":"Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study","volume":"137","author":"Wang","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115745_b1080","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2018.03.004","article-title":"Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element","volume":"150","author":"Galasiti Kankanamalage","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b1085","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bmc.2018.12.019","article-title":"Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor","volume":"27","author":"Ohnishi","year":"2019","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.bmc.2020.115745_b1090","doi-asserted-by":"crossref","unstructured":"Yoshizawa S ichiro, Hattori Y, Kobayashi K, Akaji K. Evaluation of an octahydroisochromene scaffold used as a novel SARS 3CL protease inhibitor. Bioorganic Med Chem. 2020;28(4):115273. doi:10.1016\/j.bmc.2019.115273.","DOI":"10.1016\/j.bmc.2019.115273"},{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b1095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s13238-013-2841-3","article-title":"The newly emerged SARS-Like coronavirus HCoV-EMC also has an \u201cAchilles\u2019\u2019 heel\u201c: Current effective inhibitor targeting a 3C-like protease\u201d","volume":"4","author":"Ren","year":"2013","journal-title":"Protein Cell"},{"issue":"10","key":"10.1016\/j.bmc.2020.115745_b1100","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases. Bjorkman P, ed.","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol"},{"key":"10.1016\/j.bmc.2020.115745_b1105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2012.10.053","article-title":"Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases","volume":"59","author":"Chuck","year":"2013","journal-title":"Eur J Med Chem"},{"issue":"23","key":"10.1016\/j.bmc.2020.115745_b1110","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1016\/j.bmcl.2013.09.070","article-title":"Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors","volume":"23","author":"Prior","year":"2013","journal-title":"Bioorganic Med Chem Lett"},{"issue":"12","key":"10.1016\/j.bmc.2020.115745_b1115","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1016\/j.bmcl.2010.04.118","article-title":"Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease","volume":"20","author":"Ramajayam","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"24","key":"10.1016\/j.bmc.2020.115745_b1120","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1016\/j.bmc.2006.09.014","article-title":"Binding interaction of quercetin-3-\u03b2-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure\u2013activity relationship studies reveal salient pharmacophore features","volume":"14","author":"Chen","year":"2006","journal-title":"Bioorg Med Chem"},{"issue":"22","key":"10.1016\/j.bmc.2020.115745_b1125","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1016\/j.bmc.2010.09.035","article-title":"Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition","volume":"18","author":"Ryu","year":"2010","journal-title":"Bioorganic Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b1130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2005.07.002","article-title":"Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds","volume":"68","author":"Lin","year":"2005","journal-title":"Antiviral Res"},{"issue":"17","key":"10.1016\/j.bmc.2020.115745_b1135","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1016\/j.bmc.2005.05.065","article-title":"Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic \u03b1, \u03b2-unsaturated esters","volume":"13","author":"Shie","year":"2005","journal-title":"Bioorganic Med Chem"},{"issue":"8","key":"10.1016\/j.bmc.2020.115745_b1140","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1016\/j.bmc.2008.02.040","article-title":"Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease","volume":"16","author":"Shao","year":"2008","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b1145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bmc.2012.11.017","article-title":"Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety","volume":"21","author":"Konno","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2020.115745_b1150","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejmech.2013.05.005","article-title":"Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure\u2013activity relationship study","volume":"65","author":"Thanigaimalai","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115745_b1155","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2013.07.037","article-title":"Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies","volume":"68","author":"Thanigaimalai","year":"2013","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b1160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2005.05.095","article-title":"Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease","volume":"333","author":"Liu","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.bmc.2020.115745_b1165","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.chembiol.2004.08.011","article-title":"High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase","volume":"11","author":"Blanchard","year":"2004","journal-title":"Chem Biol"},{"issue":"12","key":"10.1016\/j.bmc.2020.115745_b1170","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1021\/jm050852f","article-title":"Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies","volume":"49","author":"Tsai","year":"2006","journal-title":"J Med Chem"},{"issue":"17","key":"10.1016\/j.bmc.2020.115745_b1175","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/jm070295s","article-title":"Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus","volume":"50","author":"Wen","year":"2007","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2020.115745_b1180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bioorg.2008.01.001","article-title":"Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase","volume":"36","author":"Zhang","year":"2008","journal-title":"Bioorg Chem"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b1185","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.antiviral.2008.05.005","article-title":"High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery","volume":"80","author":"Ge","year":"2008","journal-title":"Antiviral Res"},{"issue":"9","key":"10.1016\/j.bmc.2020.115745_b1190","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.chembiol.2004.07.013","article-title":"Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics","volume":"11","author":"Kao","year":"2004","journal-title":"Chem Biol"},{"issue":"7","key":"10.1016\/j.bmc.2020.115745_b1195","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1016\/j.bmc.2008.01.011","article-title":"Structure-based virtual screening against SARS-3CLpro to identify novel non-peptidic hits","volume":"16","author":"Mukherjee","year":"2008","journal-title":"Bioorganic Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b1200","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm301580n","article-title":"Discovery, synthesis, and structure-based optimization of a series of N -(tert -Butyl)-2-(N -arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL","volume":"56","author":"Jacobs","year":"2013","journal-title":"J Med Chem"},{"issue":"13","key":"10.1016\/j.bmc.2020.115745_b1205","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1016\/j.bmc.2013.04.026","article-title":"Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava","volume":"21","author":"Park","year":"2013","journal-title":"Bioorganic Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b1210","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bmc.2013.11.041","article-title":"Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings","volume":"22","author":"Lee","year":"2014","journal-title":"Bioorganic Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b1215","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bmc.2013.11.028","article-title":"Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors","volume":"22","author":"Liu","year":"2014","journal-title":"Bioorg Med Chem"},{"issue":"12","key":"10.1016\/j.bmc.2020.115745_b1220","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1016\/j.bmcl.2005.04.027","article-title":"Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors","volume":"15","author":"Chen","year":"2005","journal-title":"Bioorganic Med Chem Lett"},{"issue":"17","key":"10.1016\/j.bmc.2020.115745_b1225","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1021\/jm060207o","article-title":"Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease","volume":"49","author":"Lu","year":"2006","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b1230","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bmc.2007.09.034","article-title":"Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro","volume":"16","author":"Niu","year":"2008","journal-title":"Bioorganic Med Chem"},{"issue":"22","key":"10.1016\/j.bmc.2020.115745_b1235","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1016\/j.bmcl.2013.08.112","article-title":"Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding","volume":"23","author":"Turlington","year":"2013","journal-title":"Bioorganic Med Chem Lett"},{"issue":"23","key":"10.1016\/j.bmc.2020.115745_b1240","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1021\/jm200870n","article-title":"Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors","volume":"54","author":"Akaji","year":"2011","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b1245","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","article-title":"Inhibition of SARS-CoV 3CL protease by flavonoids","volume":"35","author":"Jo","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b1250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/14756366.2014.1003215","article-title":"Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV","volume":"31","author":"Park","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"22","key":"10.1016\/j.bmc.2020.115745_b1255","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1016\/j.bmc.2010.09.050","article-title":"Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors","volume":"18","author":"Ramajayam","year":"2010","journal-title":"Bioorganic Med Chem"},{"issue":"16","key":"10.1016\/j.bmc.2020.115745_b1260","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1021\/jm900611t","article-title":"Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome\u2212coronavirus papain-like protease","volume":"52","author":"Ghosh","year":"2009","journal-title":"J Med Chem"},{"issue":"November 2017","key":"10.1016\/j.bmc.2020.115745_b1265","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.antiviral.2017.12.015","article-title":"Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes","volume":"150","author":"Lin","year":"2018","journal-title":"Antiviral Res"},{"issue":"8","key":"10.1016\/j.bmc.2020.115745_b1270","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bcp.2008.01.005","article-title":"Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus","volume":"75","author":"Chou","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.bmc.2020.115745_b1275","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bmc.2019.03.050","article-title":"Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling","volume":"27","author":"Lee","year":"2019","journal-title":"Bioorganic Med Chem"},{"issue":"19","key":"10.1016\/j.bmc.2020.115745_b1280","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1016\/j.bmc.2012.07.038","article-title":"Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases","volume":"20","author":"Park","year":"2012","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.bmc.2020.115745_b1285","doi-asserted-by":"crossref","unstructured":"Cho JK, Curtis-Long MJ, Lee KH, et al. Corrigendum to \u201cGeranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa\u201d [Bioorg. Med. Chem. 21 (2013) 3051\u20133057]. Bioorg Med Chem. 2013;21(22):7229. doi:10.1016\/j.bmc.2013.09.005.","DOI":"10.1016\/j.bmc.2013.09.005"},{"issue":"6","key":"10.1016\/j.bmc.2020.115745_b1290","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1021\/jm401712t","article-title":"X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases","volume":"57","author":"B\u00e1ez-Santos","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115745_b1295","doi-asserted-by":"crossref","unstructured":"W\u0119glarz-Tomczak E, Tomczak JM, Talma M, Brul S. Ebselen as a highly active inhibitor of PLProCoV2. bioRxiv. Published online 2020:2020.05.17.100768. doi:10.1101\/2020.05.17.100768.","DOI":"10.1101\/2020.05.17.100768"},{"issue":"9","key":"10.1016\/j.bmc.2020.115745_b1300","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1128\/AAC.00957-12","article-title":"Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase","volume":"56","author":"Adedeji","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.bmc.2020.115745_b1305","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/AAC.02994-14","article-title":"Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and middle east respiratory syndrome coronaviruses","volume":"58","author":"Adedeji","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b1310","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2478\/acph-2020-0024","article-title":"Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors","volume":"70","author":"Zaher","year":"2020","journal-title":"Acta Pharm"},{"key":"10.1016\/j.bmc.2020.115745_b1315","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1039\/b709515e","article-title":"Inhibition of SARS coronavirus helicase by bismuth complexes","volume":"42","author":"Yang","year":"2007","journal-title":"Chem Commun"},{"issue":"3","key":"10.1016\/j.bmc.2020.115745_b1320","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.chembiol.2005.01.006","article-title":"The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus","volume":"12","author":"Tanner","year":"2005","journal-title":"Chem Biol"},{"issue":"11","key":"10.1016\/j.bmc.2020.115745_b1325","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1016\/j.ejmech.2011.09.005","article-title":"2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV)","volume":"46","author":"Kim","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115745_b1330","doi-asserted-by":"crossref","first-page":"112557","DOI":"10.1016\/j.ejmech.2020.112557","article-title":"Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase","volume":"201","author":"Ahmed-Belkacem","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2020.115745_b1335","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1107\/S1399004715003521","article-title":"Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity","volume":"71","author":"Needle","year":"2015","journal-title":"Acta Crystallogr Sect D Biol Crystallogr"},{"issue":"18","key":"10.1016\/j.bmc.2020.115745_b1340","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1111\/febs.12936","article-title":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design","volume":"281","author":"Hilgenfeld","year":"2014","journal-title":"FEBS J"},{"key":"10.1016\/j.bmc.2020.115745_b1345","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.virusres.2015.05.018","article-title":"Prediction and biochemical analysis of putative cleavage sites of the 3C-like protease of Middle East respiratory syndrome coronavirus","volume":"208","author":"Wu","year":"2015","journal-title":"Virus Res"},{"issue":"6","key":"10.1016\/j.bmc.2020.115745_b1350","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1021\/cb500917m","article-title":"Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV","volume":"10","author":"Lee","year":"2015","journal-title":"ACS Chem Biol"},{"issue":"2","key":"10.1016\/j.bmc.2020.115745_b1355","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of the active site in proteases. I. Papain","volume":"27","author":"Schechter","year":"1967","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"10.1016\/j.bmc.2020.115745_b1360","doi-asserted-by":"crossref","first-page":"13190","DOI":"10.1073\/pnas.1835675100","article-title":"The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor","volume":"100","author":"Yang","year":"2003","journal-title":"Proc Natl Acad Sci"},{"issue":"7811","key":"10.1016\/j.bmc.2020.115745_b1365","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bmc.2020.115745_b1370","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1573409913666170519112758","article-title":"Molecular docking studies applied to a dataset of cruzain inhibitors","volume":"14","author":"da Silva-Junior","year":"2017","journal-title":"Curr Comput Aided Drug Des"},{"key":"10.1016\/j.bmc.2020.115745_b1375","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2020.04.006","article-title":"D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19","author":"Shi","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2020.115745_b1380","doi-asserted-by":"crossref","unstructured":"Ratia K, Kilianski A, Baez-Santos YM, Baker SC, Mesecar A. Structural basis for the ubiquitin-linkage specificity and deISGylating activity of SARS-CoV papain-like protease. Rey FA, ed. PLoS Pathog. 2014;10(5):e1004113. doi:10.1371\/journal.ppat.1004113.","DOI":"10.1371\/journal.ppat.1004113"},{"key":"10.1016\/j.bmc.2020.115745_b1385","article-title":"The crystal structure of papain-like protease of SARS CoV-2","author":"Osipiuk","year":"2020","journal-title":"Cent Struct Genomics Infect Dis"},{"issue":"11","key":"10.1016\/j.bmc.2020.115745_b1390","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2174\/138161206776361147","article-title":"Understanding helicases as a means of virus control","volume":"12","author":"Frick","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2020.115745_b1395","doi-asserted-by":"crossref","unstructured":"Hao W, Wojdyla JA, Zhao R, et al. Crystal structure of Middle East respiratory syndrome coronavirus helicase. Fremont DH, ed. PLOS Pathog. 2017;13(6):e1006474. doi:10.1371\/journal.ppat.1006474.","DOI":"10.1371\/journal.ppat.1006474"},{"issue":"11","key":"10.1016\/j.bmc.2020.115745_b1400","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1128\/JVI.03259-15","article-title":"Mutagenesis of coronavirus nsp14 reveals its potential role in modulation of the innate immune response. Perlman S, ed.","volume":"90","author":"Becares","year":"2016","journal-title":"J Virol"},{"issue":"30","key":"10.1016\/j.bmc.2020.115745_b1405","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1073\/pnas.1508686112","article-title":"Structural basis and functional analysis of the SARS coronavirus nsp14\u2013nsp10 complex","volume":"112","author":"Ma","year":"2015","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.bmc.2020.115745_b1410","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/v12040360","article-title":"Structural genomics of SARS-CoV-2 indicates evolutionary conserved functional regions of viral proteins","volume":"12","author":"Srinivasan","year":"2020","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.bmc.2020.115745_b1415","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jmb.2006.11.073","article-title":"Production of authentic SARS-CoV Mpro with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction","volume":"366","author":"Xue","year":"2007","journal-title":"J Mol Biol"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620305757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620305757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:09:35Z","timestamp":1760836175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089620305757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":283,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0968089620305757"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115745","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Druggable targets from coronaviruses for designing new antiviral drugs","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115745"}}